Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Bridge to New Markets.

Hadean Ventures invests in Austrian Biotech Themis Bioscience

Hadean’s Managing Partner Walter Stockinger, MS PhD © Hadean Ventures

In addition, all existing investors participated in the round, including Global Health Investment Funds, aws Gruenderfonds, Omnes Capital, Ventech and Wellington Partners.
Themis Biosciences is a Vienna-based biotech company with a lead vaccine candidate for the infectious disease called Chikungunya. The word chikungunya has been derived from a description in the Makonde language, meaning "that which bends up", of the contorted posture of people affected with the severe joint pain and arthritic symptoms associated with this disease. These symptoms, amongst other symptoms that the disease causes, have a significant debilitating effect. A large number of infected individuals also develop chronic disease that can last for months and even years.

Themis' vaccine candidate has already shown excellent results in phase II clinical trials and will be entering phase III within the next few months. It has received Fast Track designation by the US regulatory authorities, the FDA.

Hadean Ventures is a European life science fund manager that invests in life science companies across Europe with particular focus on under-ventured regions. Hadean Ventures has offices in Oslo and Stockholm and is managing funds backed by leading European and US-based private and institutional investors. On Hadean's side, the Themis investment was steered by Hadean Managing Partner, Walter Stockinger, an Austrian national with close connection to the Austrian start-up scene.
In addition to the private funding, Themis has received financial backing from CEPI (Coalition for Epidemic Preparedness Innovation), an Oslo-headquartered public-private global organization supported by amongst others the Gates Foundation and the Norwegian government.

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • ABA's Virtual Open Day

    28.05.2020 / 8.30 - 18.00, Online event

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

More testimonials

news from the business location Austria

Less gold is sometimes better

Using an ultra-thin gold layer, scientists at the Vienna University of Technology succeeded in creating an almost optimal infrared absorber.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts